{{Rsnum
|rsid=2445142
|Gene=HSPG2
|Chromosome=1
|position=21899250
|Orientation=plus
|GMAF=0.4734
|Gene_s=HSPG2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 13.3 | 40.7 | 46.0
| HCB | 38.7 | 48.2 | 13.1
| JPT | 36.3 | 48.7 | 15.0
| YRI | 41.5 | 45.6 | 12.9
| ASW | 49.1 | 42.1 | 8.8
| CHB | 38.7 | 48.2 | 13.1
| CHD | 42.2 | 37.6 | 20.2
| GIH | 7.9 | 49.5 | 42.6
| LWK | 52.7 | 40.9 | 6.4
| MEX | 34.5 | 46.6 | 19.0
| MKK | 51.3 | 38.5 | 10.3
| TSI | 2.9 | 41.2 | 55.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20072119
|Title=Association of the HSPG2 Gene with Neuroleptic-Induced Tardive Dyskinesia
|OA=1
}}

{{PMID Auto
|PMID=21808285
|Title=Support for association of HSPG2 with tardive dyskinesia in Caucasian populations
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}